Literature DB >> 31356771

Telemedicine for medication abortion.

Ushma D Upadhyay1, Daniel Grossman2.   

Abstract

Keywords:  Abortion; Food and Drug Administration (FDA); Medication abortion; Telemedicine

Mesh：

Substances：

Year:  2019        PMID： 31356771     DOI： 10.1016/j.contraception.2019.07.005

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  4 in total

1.  Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19.

Authors:  Ushma D Upadhyay; Rosalyn Schroeder; Sarah C M Roberts
Journal:  Contracept X       Date:  2020-11-21

2.  Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol.

Authors:  Ellen R Wiebe; Mackenzie Campbell; Harani Ramasamy; Michaela Kelly
Journal:  Contracept X       Date:  2020-04-11

3.  Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.

Authors:  Elizabeth G Raymond; Daniel Grossman; Alice Mark; Ushma D Upadhyay; Gillian Dean; Mitchell D Creinin; Leah Coplon; Jamila Perritt; Jessica M Atrio; DeShawn Taylor; Marji Gold
Journal:  Contraception       Date:  2020-04-16       Impact factor: 3.375

4.  Attitudes of US adults toward using telemedicine to prescribe medication abortion during COVID-19: a mixed methods study.

Authors:  Kathryn J LaRoche; Kristen N Jozkowski; Brandon L Crawford; Katherine R Haus
Journal:  Contraception       Date:  2021-04-10       Impact factor: 3.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.